For years, Tir Medical's entire identity was built around its TourniTek product — a portable medical device that provides limb immobilization and localized thermal therapy for pre-hospital emergency care. One device, one market, one name. But nearly a decade of building and testing alongside clinicians at the University of Washington and UCSF changed that. The device grew into a company, and the company needed a name that could hold more than one product and more than one ambition.
"The change signals that we've stopped thinking of ourselves as a tourniquet company and started thinking of ourselves as a trauma-care company," the team says.
Those early academic partnerships shaped more than the product roadmap. Working with clinicians and researchers forced the team to design for the problem as it actually presents in the field, not the version they imagined from the outside. "We build to what a clinician or first responder will actually trust under pressure, not just what passes a bench test."
The company's technology addresses hemorrhage — the leading cause of preventable death in trauma — with devices designed to work in the most austere, high-pressure environments imaginable. That's also what makes the defence application so natural. "The physiology doesn't care about the setting," the team says. "Defence is the most demanding proving ground; if it performs there, the civilian case follows." Rather than choosing between markets, Tir Medical thinks in terms of sequencing — proving the technology in defence first, then letting that credibility carry into civilian applications.
Building defence relationships has required the same deliberateness. "Defence procurement rewards patience and proof," the team says. "Those relationships start with credibility — surgeon-to-surgeon — and move at the speed of trust and evaluation."
Tir Medical is a Washington State-based company, which makes its engagement with the B.C. ecosystem worth noting. The team points to proximity as the most valuable thing Canada has offered: a small enough ecosystem that the right people are a short conversation away, and introductions compound quickly. "A year of relationship-building happens in a quarter."
The company has been through both CDL-Vancouver and the UBC Sauder Scale Up Program — one of eight ventures in the program's pilot cohort. The two solved different problems at different stages. CDL sharpened judgment about where to point the company; Scale Up is more operational, focused on building the pipeline and partnerships to grow it. "CDL helped us decide where to point the company; Scale Up is helping us get there faster."
